• Home
  • The Hospital
    • On the page
      • All Institutionsfrom A to Z
      • More about the clinic
      • Management and administration
      • Facts and figures
      • Press releases
      Further topics
      • Mission
      • Quality
      • Ernährung am Klinikum
      • Nursing at the clinic
      • Data protection at the clinic
  • Patients & Visitors
    • On the page
      • Treatment and stay
      • Hospital-Finder
      • On-site orientation
      • Clinical Trials
      • Social News Feed
      Further topics
      • Social counseling and care transition
      • Treatment costs and optional services
      • Information and consent
  • Faculty of Medicine
    • On the page
      • Research | Study and teaching
      • Academic Career
  • Career
    • On the page
      • Application and your start
      • Your career paths
      • Further training
      • Hospital and Medical Faculty as employer
      Further topics
      • Training occupations
      • International nurses
      • Internships
  • Contact
    • On the page
      • Contacting the University Hospital
      • Emergency and first aid
      • Contact for patients, relatives and donors
      • Directions
      • Management and administration
      • All facilities from A to Z
      • Media contact
      Further topics
      • Spenden und Sponsoring
      • Feedback
  • English
  • Impressum
  • Datenschutz
Go to the main content
  • The Hospital
    On the page
    • All Institutionsfrom A to Z
    • More about the clinic
    • Management and administration
    • Facts and figures
    • Press releases
    Further topics
    • Mission
    • Quality
    • Ernährung am Klinikum
    • Nursing at the clinic
    • Data protection at the clinic
  • Patients & Visitors
    On the page
    • Treatment and stay
    • Hospital-Finder
    • On-site orientation
    • Clinical Trials
    • Social News Feed
    Further topics
    • Social counseling and care transition
    • Treatment costs and optional services
    • Information and consent
  • Faculty of Medicine
    On the page
    • Research | Study and teaching
    • Academic Career
  • Career
    On the page
    • Application and your start
    • Your career paths
    • Further training
    • Hospital and Medical Faculty as employer
    Further topics
    • Training occupations
    • International nurses
    • Internships
  • Contact
    On the page
    • Contacting the University Hospital
    • Emergency and first aid
    • Contact for patients, relatives and donors
    • Directions
    • Management and administration
    • All facilities from A to Z
    • Media contact
    Further topics
    • Spenden und Sponsoring
    • Feedback
International Patients
Press
Logo

iFIT Cluster of Excellence Newsletter Vol. V

rocket

Dear members & friends,

 

With our Email Newsletter, we want to keep you up to date with all new information surrounding our “Image-Guided and Functionally Instructed Tumor Therapies” Cluster of Excellence. Vol. V includes news, publications and general information from the past three months and upcoming events. The next newsletter will be published on June 1, 2024.

 

If you have any comments or feedback feel free to get in touch with us: ifitoffice@med.uni-tuebingen.de

 

With best regards,

 

iFIT Office Team

 

News

 

iFIT Video

Aftermovie of the Science Fair 2023

Learn more

iFIT News

Juliane Walz elected as new iFIT spokesperson

Learn more

iFIT News

Attempto Article: Seeing through tumors 

Learn more

iFIT News

Farewell Barbara!

Learn more

iFIT Video

World Cancer Day 2024

Learn more

iFIT Video

International Day of Women & Girls in Science 2024

Learn more

iFIT Video

Juliane Walz & Helmut Salih part of Campus TV Show regarding Immunotherapies

Learn more

iFIT News

Welcome back, Ines!

Learn more
 

Get to know...

 

Anna Junker

Learn more

Judith Feucht

Learn more

Josef Leibold

Learn more
 

Upcoming Events

Workshop

Excellence workshop Module I with Dr. Paul Charlton

5th of March 2024 from 09:30am -  05:00 pm
iFIT Seminar Room, Röntgenweg 11

Seminar Series

iFIT Seminar Series with Steven Johnson

11th of March 2024 at 12:15pm

CRONA HS 210, Hoppe-Seyler-Straße 3

Learn more

Lunch & Learn

iFIT Lunch & Learn Session with Saskia Biskup

20th of March 2024 at 12:30pm

HNO Clinic, Lecture hall, Elfriede-Aulhorn-Straße 5 

Seminar Series

iFIT Seminar Series with Robert F. Schwabe

15th of April 2024 at 12:00am

HNO Clinic, Lecture hall, Elfriede-Aulhorn-Straße 5

Lunch & Learn

iFIT Lunch & Learn Session with Benjamin Bender

24th of April 2024 at 12:30pm

HNO Clinic, Lecture hall, Elfriede-Aulhorn-Straße 5

Workshop

Fundamentals of Scientific Writing with Birgit Hollenbach

6th - 7th of May 2024 from 09:00am - 05:00pm

iFIT Seminar Room, Röntgenweg 11

Seminar Series

iFIT Seminar Series with Timour Baslan

13th of May 2024 at 12:00pm
CRONA HS 210, Hoppe-Seyler-Straße 3

 

Selected Publications

Acidosis-mediated increase in IFN-γ-induced PD-L1 expression on cancer cells as an immune escape mechanism in solid tumors

Knopf, P., Stowbur, D., Hoffmann, S.H.L. et al. Acidosis-mediated increase in IFN-γ-induced PD-L1 expression on cancer cells as an immune escape mechanism in solid tumors. Mol Cancer 22, 207 (2023). https://doi.org/10.118/s12943-023-01900-0
IF: 37.3

 

Somatic mouse models of gastric cancer reveal genotype-specific features of metastatic disease

Leibold, J., Tsanov, K.M., Amor, C. et al. Somatic mouse models of gastric cancer reveal genotype-specific features of metastatic disease. Nat Cancer 5, 315–329 (2024). https://doi.org/10.1038/s43018-023-00686-w IF: 22.7

 

Detection of senescence using machine learning algorithms based on nuclear features

Duran, I., Pombo, J., Sun, B. et al. Detection of senescence using machine learning algorithms based on nuclear features. Nat Commun 15, 1041 (2024). https://doi.org/10.1038/s41467-024-45421-w IF: 16.6

 

Augmenting MEK inhibitor efficacy in BRAF wild-type melanoma: synergistic effects of disulfiram combination therapy

Torres, F., Niessner, H., Plöger, S. et al. Augmenting MEK inhibitor efficacy in BRAF wild-type melanoma: synergistic effects of disulfiram combination therapy . J Exp Clin Cancer Res. Jan 23;43(1):30 (2024). 10.1186/s13046-023-02941-5 IF: 11.3

 

Image-guided metabolomics and transcriptomics reveal tumour heterogeneity in luminal A and B human breast cancer beyond glucose tracer uptake

Yang, Q., Deng, S., Preibsch, H. et al. Image-guided metabolomics and transcriptomics reveal tumour heterogeneity in luminal A and B human breast cancer beyond glucose tracer uptake. Clin Trans Med. Feb; 14(2):e1550 (2024) 10.1002/ctm2.1550 IF: 10.6

 

An Fc-modified monoclonal antibody as novel treatment option for pancreatic cancer

Lutz, M., Wang, K., Jung, G. et. al. An Fc-modified monoclonal antibody as novel treatment option for pancreatic cancer. Front Immunol. Jan 22:15:1343929. (2024)  10.3389/fimmu.2024.1343929 IF: 7.3

 

Job Offers

Scientific Coordinator

iFIT Office

Learn more

Project Coordinator

iFIT Office

Learn more

Follow us on social media

Twitter LinkedInYouTube

 

Legal Notice

 

Cluster of Excellence

“Image-Guided and Functionally Instructed Tumor Therapies” (iFIT)
Röntgenweg 11
72076  Tübingen, Germany

 

Contact:

Public Relations
Steven Pohl

Mail: steven.patrick.pohl@med.uni-tuebingen.de

 

Click here to unsubscribe  

Back to top

Emergency

  • 112 rescue service germany
  • 116 117 on-duty medical service germany
  • 0761 19240 poisoning germany
  • Childbirth
  • Emergencies and wards
  • Emergency stand-by

The University Hospital

  • Our Institutions A-Z
  • Facts and figures
  • History
  • Quality
  • Management and administration
  • Communications and Media Relations
  • Donations

Patients and Visitors

  • International patients
  • Outpatient appointments
  • Hospitalization
  • Feedback

Faculty of Medicine

  • Doctoral Studies
  • Research
  • Institutes
  • Deanery and faculty council

© 2025 University Hospital and Faculty of Medicine Tübingen

  • Career
  • Contact
  • Imprint
  • Privacy Policy
  • Accessibility
  • Cookies
Cookie Einstellungen
Bitte treffen Sie eine Auswahl um fortzufahren.
Weitere Informationen zu den Auswirkungen Ihrer Auswahl finden Sie unter Hilfe.
 
Um fortfahren zu können, müssen Sie eine Cookie-Auswahl treffen.

Cookies zulassen:
Wir setzen das Analysetool Google Analytics ein, um Besucher-Informationen wie z.B. Browser, Land, oder die Dauer, wie lange ein Benutzer auf unserer Seite verweilt, zu messen. Ihre IP-Adresse wird anonymisiert übertragen, die Verbindung zu Google ist verschlüsselt.

Nur notwendige Cookies zulassen:
Wir verzichten auf den Einsatz von Analysetools. Es werden jedoch technisch notwendige Cookies, die eine reibungslose Navigation und Nutzung der Webseite ermöglichen, gesetzt (beispielsweise den Zugang zum zugangsbeschränkten Bereich erlauben).

Sie können Ihre Cookie-Einstellung jederzeit auf der Seite Datenschutzerklärung ändern. Zum Impressum.

Zurück